Blogs

When Transparency Becomes a Blunt Instrument

Getting the Big Picture: Notes From ISPE's 2008 Annual Meeting

Pharma’s latest political stance

Like a Broken Record: California Delays Pedigree Legislation

Pharma’s Worst Nightmare? Dingell, Grassley Have Plans for FDA